Investing.com - Sensei Biotherapeutics reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that was in line with expectations. Sensei Biotherapeutics announced ...
Sensei Biotherapeutics's stock price closed at $0.77. It is up 11.59% in the last 3 months and down -49.10% in the last 12 months. Sensei Biotherapeutics saw 2 positive EPS revisions and 0 negative ...
Sensei Biotherapeutics, Inc. SNSE surged on Wednesday following the company’s announcement of its acquisition of Faeth Therapeutics Inc. and a concurrent $200 million private investment. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results